Dr. Maakaron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton St SE
MMC 2121BD
Minneapolis, MN 55455Phone+1 612-676-4200Fax+1 612-676-4004
Summary
- I am a hematologist and medical oncologist specializing in treatment of blood cancers (leukemias and lymphomas) with bone marrow transplantation and cellular therapies.
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
Indiana University School of MedicineResidency, Internal Medicine, 2013 - 2016
American University of Beirut Faculty of MedicineClass of 2011, MD, AOA
Certifications & Licensure
MN State Medical License Active through 2025
OH State Medical License 2016 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha 2011
Clinical Trials
- Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel Start of enrollment: 2020 Aug 06
Publications & Presentations
PubMed
- 199 citationsAxicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and ToxicityCaron A. Jacobson, Bradley D. Hunter, Robert A. Redd, Scott J. Rodig, Pei Hsuan Chen
Journal of Clinical Oncology. 2020-07-15 - 4 citationsEfficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy.Madiha Iqbal, Deepa Jagadeesh, Julio Chavez, Arushi Khurana, Allison Rosenthal
Bone Marrow Transplantation. 2024-02-01 - 2 citationsCD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma.Priyanka A Pophali, Joshua A Fein, Kwang W Ahn, Molly Allbee-Johnson, Nausheen Ahmed
Blood Advances. 2024-10-22
Abstracts/Posters
- Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of...Joseph Maakaron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgki...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
- Member
- American Society of Transplant and Cellular TherapyMember
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
